The two companies join forces to develop tools and software compliant with the ISO/IEC 23092 MPEG-G international open standard for genome sequencing. Lausanne –GenomSys has signed a multi-year development and license agreement with Philips, a global leader in health technology, to develop tools and software compliant with the ISO/IEC 23092 MPEG-G international open standard for […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment. ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life […]

WOBURN, MA — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the pricing of its initial public offering of 3,060,000 shares of its common stock and accompanying warrants to purchase up […]

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be candidates for Servier Pharmaceuticals’ […]

IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of its newest loop-mediated isothermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG), which combines the master mix and LAMP fluorescent dye in one convenient kit. The new master mix and kit enable researchers to […]

Highly accurate HRD detection offers affordable and easily implementable solutions, opening new doors for healthcare São Paulo, Brazil and Boston, MA – Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Homologous recombination deficiency) analytics solution in Latin […]

Milestone underlines company’s global leadership in sample preparation Company’s NGS assays also hit milestone of one million samples tested since 2015 New kits and instruments will bolster QIAGEN’s position in most crucial area of molecular testing GERMANTOWN, Md. & HILDEN, Germany– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological […]

The new approach will be tested in three cohorts of patients diagnosed with Cystic Fibrosis, Alzheimer’s Disease, and Coronary Artery Disease ATLANTA, GA, UNITED STATES — Sequegenics today announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $251,073 to conduct research and development (R&D) work on a new approach […]

IPSWICH, Mass. — New England Biolabs (NEB) recently launched the NEBNext Immune Sequencing Kits, available for either human or mouse samples, to enable B-cell and/or T-cell repertoire (BCR and/or TCR) analysis of infections. The kits’ streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity. Recently published examples […]

GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission’s ongoing regulatory review. Illumina, […]